Alcohol use disorder, often called AUD, is a long-term medical condition in which people find it difficult to control their drinking even when it causes serious problems. In this study, researchers tested the oral tablet form of semaglutide rather than the injectable version. People taking semaglutide experienced fewer heavy drinking days, drank less alcohol when they did drink, reported lower alcohol cravings and had fewer alcohol-related problems. Larger and longer clinical trials will be needed before doctors can be certain how well oral semaglutide works, what dose is best and which patients benefit most. Even so, the findings suggest oral semaglutide could eventually become a valuable addition to existing treatments, particularly for people who have not responded to current medications.